Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Interferon Alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified February 2008 by National Cancer Institute (NCI).
Recruitment status was:  Active, not recruiting
Sponsor:
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00002869
First received: November 1, 1999
Last updated: December 18, 2013
Last verified: February 2008